Diasorin

Flex™ Testing with the LIAISON PLEX® Respiratory Flex Assay is helping labs and hospitals rethink respiratory diagnostics. By tailoring panels to patient needs, seasonality, or care settings, providers are empowered to deliver precise results while optimizing resources.  Read our latest blog post about the presentation by Bridget Parsons, MSPH to discover how one hospital saved $133,000 annually, all while maintaining high-quality care, by using customizable respiratory testing panels with the LIAISON PLEX System. https://hubs.li/Q03W2y2b0 #DiagnosticStewardship #RespiratoryTesting #HealthcareEfficiency #LaboratoryInnovation #CostEffectiveCare

In the latest episode of Diasorin’s Beyond the Result podcast, Dr. Kyle Rodino from the Hospital of the University of Pennsylvania joins Angelo Rago to discuss how data-driven stewardship can unlock hidden cost savings and strengthen hospital financial health. From outdated data frameworks to cross-functional collaboration, this episode dives into the real-world challenges and opportunities of modernizing diagnostics. ✅ Better patient outcomes ✅ Smarter resource use ✅ Stronger financial performance Listen on YouTube or wherever you find your podcasts: https://hubs.li/Q03VM_300 #HealthcareLeadership #HospitalStrategy #DiagnosticStewardship #BeyondTheResult #DiasorinPodcast Stephanie Ibbotson Michelle Tabb

Two new episodes of Beyond the Result are live! In our latest blog, we spotlight two insightful conversations from Beyond the Result, featuring expert voices from: • Dr. Mark Zaydman (Washington University in St. Louis) on value-based care, patient-centered diagnostics, and stewardship. • Dr. Margie Morgan (Cedars-Sinai, Los Angeles) on smarter, more flexible testing strategies. Hosted by Angelo Rago, these episodes offer practical takeaways for anyone navigating the evolving world of diagnostics. Read more: https://hubs.ly/Q03VbsyN0 #BeyondTheResult #Diasorin #HealthcareStrategy #DiagnosticStewardship Stephanie IbbotsonMichelle Tabb

"Diagnostic stewardship is increasingly critical as clinical laboratories navigate financial pressures and personnel shortages. Diasorin is committed to easing this burden by expanding our portfolio of flexible syndromic testing solutions” commented Angelo Rago, President of Luminex. Read more: https://lnkd.in/dgfZCbV7

We are proud to share that Diasorin Immuno Global Operations has received the First Prize HRBP2025 – Human Strategy from ALES – European Lean Managers Society. This award recognizes our commitment to capability building and change management through the Global Immuno Technical Academy, designed to harmonize manufacturing processes across regions, scale best practices globally, and build the technical skills essential for efficiency, quality, and competitiveness. The recognition highlights an integrated approach: strong governance, an internal faculty of experts, a methodology based on skills gap analysis, and an evolving blended learning journey. Thank you to ALES for acknowledging the value of this initiative and to all our people who made it possible! #HRBP2025 #CapabilityBuilding #ChangeManagement #LeanLeadership #Diasorin

Adding a new test to your lab menu isn’t just a clinical decision; it’s a business one as well. Diasorin’s Market Access team helps labs with tools and guidance that reduce risk and support smarter decisions. From reimbursement education to coding support, we are here to help. Learn how Market Access can drive confident test adoption. https://hubs.ly/Q03VbxCl0 #Diagnostics #MarketAccess #HealthcareSolutions #TeamworkInHealth #LifeSciences

We’re proud to share that the Simplexa® COVID-19 / Flu A/B & RSV Direct assay has received FDA 510(k) clearance, empowering labs to deliver rapid, reliable results for four common respiratory viruses. This means:  • Faster diagnoses for patients with respiratory symptoms • Streamlined workflows for your lab team • Better-informed treatment decisions • Stronger infection control in your healthcare setting With results in ~50 minutes, this assay helps you make a difference — one test, four answers, real impact. Learn more about the Simplexa COVID-19 / Flu A/B & RSV Direct assay at https://hubs.li/Q03SkcgH0 #Diasorin #Simplexa #MolecularDiagnostics #RespiratoryTesting #LaboratoryMedicine #DiagnosticStewardship

It’s World Antibiotic Awareness Week, and Diasorin is excited to stand with the World Health Organization in championing smart, responsible use of antibiotics. At Diasorin, we believe innovation in diagnostics can make a real difference. By giving clinicians fast, reliable tools, we help support confident decisions that keep patients healthy and protect the long-term effectiveness of antibiotics. Small actions, smart testing, and shared awareness can create a big impact. Let’s keep moving forward together. #AMR, #LIAISONMeMedBV, #BacterialOrViral, #WHO, #StopAntimicrobialResistance

The new assay will deliver significant testing productivity and faster results compared to the current solution on the market, and it will be launched in all Countries accepting the CE Mark. Read more: https://lnkd.in/dAyd-dJA

In this episode of Beyond the Result, Dr. Kyle Rodino from the Hospital of the University of Pennsylvania joins host Angelo Rago to explore how diagnostic stewardship is reshaping lab operations and hospital strategy. Key takeaways: • Faster lab results = better patient care • Cross-department collaboration is essential • Smarter data use can reveal hidden savings • Future diagnostics will be more tailored and efficient Listen on YouTube or wherever you find your podcasts: https://hubs.li/Q03Tn43L0 #HealthcareInnovation #DiagnosticStewardship #HospitalFinance #BeyondTheResult #DiasorinPodcast Michelle Tabb Stephanie Ibbotson